Clinical Trials Logo

Health Volunteers clinical trials

View clinical trials related to Health Volunteers.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05478772 Completed - Health Volunteers Clinical Trials

Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects

Start date: July 11, 2022
Phase: Phase 1
Study type: Interventional

A single center, Phase 1, open-label, fixed-sequence, drug-drug interaction study to evaluate the effect of multiple doses of Fluconazole, a CYP3A4 and CYP2C9 inhibitor, on the pharmacokinetics (PK) of CTP-543 in healthy subjects

NCT ID: NCT05467709 Completed - Health Volunteers Clinical Trials

Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects

Start date: June 21, 2022
Phase: Phase 1
Study type: Interventional

This is a single center, Phase 1, open-label, fixed-sequence, drug-drug interaction study to determine the effect of CTP-543 on the pharmacokinetics (PK) of midazolam in healthy adult subjects

NCT ID: NCT05467696 Completed - Health Volunteers Clinical Trials

Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers

Start date: June 14, 2022
Phase: Phase 1
Study type: Interventional

This is an open-label, single-dose, two period crossover study to evaluate the effect of food on the bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers

NCT ID: NCT02990325 Completed - HIV Infections Clinical Trials

A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults

Start date: March 27, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the ABX464-005 study is to characterize the systemic and mucosal immunological sequelae associated with exposure to ABX464 and to explore selected immunological endpoints, compartmental pharmacokinetics, and pharmacodynamics.

NCT ID: NCT01765855 Completed - Health Volunteers Clinical Trials

An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects

Start date: September 2007
Phase: Phase 1
Study type: Interventional

This is a open label, single center, single oral dose, study of PRT054021, in healthy subjects.